KROMATID Selected as Industry Resource Partnership Program Member by the California Institute for Regenerative Medicine (CIRM)
Expands access to high-resolution, single-cell genomic analysis throughout cell and gene therapy development BOULDER, Colo., Oct. 27, 2026 /PRNewswire/ -- KROMATID, a leader in analytical cytogenetics for the cell and gene therapy industry, announced today it has been selected to be a...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.